Evidence map›Paper›PMID 32128556›Full record

ArticleAnnals of behavioral medicine : a publication of the Society of Behavioral Medicine2020

PMTCT Adherence in Pregnant South African Women: The Role of Depression, Social Support, Stigma, and Structural Barriers to Care.

Christina Psaros, Jennifer A Smit, Nzwakie Mosery, Kara Bennett, Jessica N Coleman, David R Bangsberg, Steven A Safren

Abstract read
In one paragraph

Article in Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christina PsarosBehavioral Medicine Program, Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Jennifer A SmitMatCH Research Unit, Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa.
Nzwakie MoseryMatCH Research Unit, Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa.
Kara BennettBennett Statistical Consulting, Inc., Ballston Lake, NY.
Jessica N ColemanDepartment of Psychology and Neuroscience, Duke University, Durham, NC.
David R BangsbergSchool of Public Health, Oregon Health Sciences University-Portland State University, Portland, OR.
Steven A SafrenDepartment of Psychology, University of Miami, Coral Gables, FL.

Funding

Perinatal Depression, Stigma, Social Capital Utilization and PMTCT AdherenceK23MH096651 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PSAROS, CHRISTINA · 2012 to 2016
$843k
NIMH NIH HHS K23 MH096651
6 · The paper itself

Abstract

backgroundDepression is a robust predictor of nonadherence to antiretroviral (ARV) therapy, which is essential to prevention of mother-to-child transmission (PMTCT). Women in resource-limited settings face additional barriers to PMTCT adherence. Although structural barriers may be minimized by social support, depression and stigma may impede access to this support. PURPOSE: To better understand modifiable factors that contribute to PMTCT adherence and inform intervention development.

methodsWe tested an ARV adherence model using data from 200 pregnant women enrolled in PMTCT (median age 28), who completed a third-trimester interview. Adherence scores were created using principal components analysis based on four questions assessing 30-day adherence. We used path analysis to assess (i) depression and stigma as predictors of social support and then (ii) the combined associations of depression, stigma, social support, and structural barriers with adherence.

resultsElevated depressive symptoms were directly associated with significantly lower adherence (est = -8.60, 95% confidence interval [-15.02, -2.18], p < .01). Individuals with increased stigma and depression were significantly less likely to utilize social support (p < .01, for both), and higher social support was associated with increased adherence (est = 7.42, 95% confidence interval [2.29, 12.58], p < .01). Structural barriers, defined by income (p = .55) and time spent traveling to clinic (p = .31), did not predict adherence.

conclusionsDepression and social support may play an important role in adherence to PMTCT care. Pregnant women living with HIV with elevated depressive symptoms and high levels of stigma may suffer from low social support. In PMTCT programs, maximizing adherence may require effective identification and treatment of depression and stigma, as well as enhancing social support.

Indexed as

Drug MonitoringSocial StigmaSocial SupportAdolescentAdultAntirheumatic AgentsDepressionFemaleHealth Services AccessibilityHIV InfectionsHumansInfectious Disease Transmission, VerticalMiddle AgedPregnancySouth AfricaYoung AdultAntirheumatic AgentsAdherenceDepressionHIVPregnancySocial supportStigmaStructural barriersVertical transmission

Identifiers

PMID32128556
PMCPMC7459185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.